Site-specific PEGylation of Human Growth Hormone by Mutated Sortase A

Abstract

Human growth hormone(hGH), a classic therapeutic protein, which promotes growth and wound healing, is released from the pituitary gland. As a protein drug, its short half-life is its main barrier to therapeutic efficacy. Various strategies have been designed to prolong its serum half-life, the most common of which is the conjugation with polyethylene glycol(PEG), as this has been shown to significantly extend protein’s serum half-life. However, PEGylation often results in random conjugation, which can lead to impaired protein function and hinder purification, characterization and evaluation of the PEGylated protein. Therefore, site specific PEGylation is a promising direction for PEG-protein conjugation. Here we took advantages of the mutated sortase A(7M) enzyme, which can enzymatically ligate the universal α-amino acids to a C-terminal tagged protein. This then allows specific modification of the C-terminal of hGH with PEG. This site-specific bound PEG-hGH has similar efficacy, receptor binding and cell proliferation as wild-type hGH; however, pharmacokinetic analysis demonstrates that its serum half-life is almost 24 times that of wild-type hGH. Herein, we provided a promising advancement in the development of site specific PEGylated therapeutic proteins.

Keywords

Human growth hormone / PEGylation / Site specific modification

References

[1] Jorgensen K. D. Acta Endocrinologica, 1987, 114(3): 124.

[2] Frasier S. D. Endocrine Reviews, 1983, 4(2): 155.

[3] Khameneh B., Saberi M. R., Hassanzadeh-Khayyat M., Moham-madpanah H., Ghandadi M., Iranshahi M., Baratian A., Jaafari M. R. Journal of Applied Biomedicine, 2016, 14(4): 257.

[4] Webster R., Xie R., Didier E., Finn R., Finnessy J., Edgington A., Walker D. Xenobiotica, 2008, 38(12): 1340.

[5] Bond W. S., Hussar D. A. American Journal of Hospital Pharmacy, 1991, 48(9): 1978.

[6] Gao Y., Xu Y., Land A., Harris J., Policastro G. M., Childers E. P., Ritzman T., Bundy J., Becker M. L. ACS Macro. Letters, 2017, 6(2): 875.

[7] Liu Y. J., Zhang P., Du J. W., Wang Y. X. Chem. J. Chinese Univer-sity, 2016, 37(5): 1003.

[8] Roberts M. J., Bentley M. D., Harris J. M. Advanced Drug Delivery Reviews, 2002, 54(1): 459.

[9] Nischan N., Hackenberger C. P. Journal of Organic Chemistry, 2014, 79(24): 10727.

[10] Veronese F. M. Biomaterials, 2001, 22(22): 405.

[11] Zalipsky S. Bioconjugate Chemistry, 1995, 6(4): 150.

[12] Kinstler O., Molineux G., Treuheit M., Ladd D., Gegg C. Advanced Drug Delivery Reviews, 2002, 54(9): 477.

[13] Mazmanian S. K., Ton-That H., Su K., Schneewind O. Proceedings of the National Academy of Sciences of the United States of America, 2002, 99(4): 2293.

[14] Mao H. Y., Hart S. A., Schink A., Pollok B. A. Journal of the American Chemical Society, 2004, 126(22): 2670.

[15] Dorr B. M., Ham H. O., An C., Chaikof E. L., Liu D. R. Proceedings of the National Academy of Sciences of the United States of America, 2014, 111(37): 13343.

[16] Glasgow J. E., Salit M. L., Cochran J. R. Journal of the American Chemical Society, 2016, 138(1): 7496.

[17] de Vos A. M., Ultsch M., Kossiakoff A. A. Science(New York), 1992, 255: 306.

[18] Yang J., Yan R., Roy A., Xu D., Poisson J., Zhang Y. Nature Methods, 2015, 12(12): 7.

[19] Abdel-Meguid S. S., Shieh H. S., Smith W. W., Dayringer H. E., Violand B. N., Bentle L. A. Proceedings of the National Academy of Sciences of the United States of America, 1987, 84(18): 6434.

[20] Popp M. W., Dougan S. K., Chuang T. Y., Spooner E., Ploegh H. L. Proceedings of the National Academy of Sciences of the United States of America, 2011, 108(16): 3169.

[21] Zhang Y., Huo M., Zhou J., Xie S. Computer Methods & Programs in Biomedicine, 2010, 99(1): 306.

[22] Cohen P., Rogol A. D., Deal C. L., Saenger P., Reiter E. O., Ross J. L., Chernausek S. D., Savage M. O., Wit J. M., Participants I. S. S. C. W. Journal of Clinical Endocrinology & Metabolism, 2008, 93(9): 4210.

[23] Lee P., Towslee J., Maia J., Pokorski J. Macromolecular Bioscience, 2015, 15(11): 1332.